Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Feel good: Share the fantasy

It isn't an exaggeration to claim that the development of new classes of drugs is saving and extending millions of lives, and in the process reshaping societies, and will do so more dramatically in the coming decades. Life-saving therapies and the companies that create them cannot, however, cure poverty, erase inequities between the North and the South, or substitute for trained doctors, modern hospitals and basic medical care.

Nevertheless, politicians at the White House, the United Nations, in the Capitol of Maine, and elsewhere last week expressed their convictions that pharmaceutical and biotech companies can be convinced or coerced into solving just those kinds of problems. The disappointment that will come with the realization that

Read the full 1147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers